ADA Scientific Sessions 2026 Abstract

Metabolic, Hepatic, Renal, and Hemodynamic Effects of DA-2811 vs. Forxiga in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Study

By Jun Hwa Hong, Kyung Ah Han, Jun Goo Kang, Sungrae Kim

Trial in peopleInterventions

The paper

Jun Hwa Hong, Kyung Ah Han, Jun Goo Kang, Sungrae Kim

Daejeon

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1844-P

doi.org/10.2337/db26-1844-p

Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial